New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas

por Seong, Gyuhee, D’Angelo, Sandra P.
Publicado 2023

小细胞肺癌的的分子发病机制

por D'ANGELO, Sandra P., Catherine PIETANZA, M., 李, 红洁, 李, 晓平
Publicado 2010

Cytokine release syndrome after radiation therapy: case report and review of the literature

por Barker, Christopher A., Kim, Samuel K., Budhu, Sadna, Matsoukas, Konstantina, Daniyan, Anthony F., D’Angelo, Sandra P.
Publicado 2018

Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival

por Manitz, Juliane, D'Angelo, Sandra P, Apolo, Andrea B, Eggleton, S Peter, Bajars, Marcis, Bohnsack, Oliver, Gulley, James L
Publicado 2022

Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 Cases

por Bartlett, Edmund K., D’Angelo, Sandra P., Kelly, Ciara M., Siegelbaum, Robert H., Fisher, Charles, Antonescu, Cristina R., Ariyan, Charlotte E.
Publicado 2021

Analysis of the Chemotherapy-Free Interval following Image-Guided Ablation in Sarcoma Patients

por Sutton, Charles, Zhang, Yachao, Kim, DaeHee, Yarmohammadi, Hooman, Ziv, Etay, Boas, Franz E., Sofocleous, Constantinos T., Tap, William D., D'Angelo, Sandra P., Erinjeri, Joseph P.
Publicado 2020

Efficacy and immune-related adverse event associations in avelumab-treated patients

por Kelly, Karen, Manitz, Juliane, Patel, Manish R, D’Angelo, Sandra P, Apolo, Andrea B, Rajan, Arun, Kasturi, Vijay, Speit, Isabell, Bajars, Marcis, Warth, John, Gulley, James L
Publicado 2020

Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinica...

por Lambert, Jérémy, Marrel, Alexia, D’Angelo, Sandra P., Burgess, Melissa A., Chmielowski, Bartosz, Fazio, Nicola, Gambichler, Thilo, Grob, Jean-Jacques, Lebbé, Céleste, Robert, Caroline, Russell, Jeffrey, Güzel, Gülseren, Bharmal, Murtuza
Publicado 2020

First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study

por D'Angelo, Sandra P, Lebbé, Celeste, Mortier, Laurent, Brohl, Andrew S, Fazio, Nicola, Grob, Jean-Jacques, Prinzi, Natalie, Hanna, Glenn J, Hassel, Jessica C, Kiecker, Felix, Georges, Sara, Ellers-Lenz, Barbara, Shah, Parantu, Güzel, Gülseren, Nghiem, Paul
Publicado 2021

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

por Kaufman, Howard L., Russell, Jeffery S., Hamid, Omid, Bhatia, Shailender, Terheyden, Patrick, D’Angelo, Sandra P., Shih, Kent C., Lebbé, Céleste, Milella, Michele, Brownell, Isaac, Lewis, Karl D., Lorch, Jochen H., von Heydebreck, Anja, Hennessy, Meliessa, Nghiem, Paul
Publicado 2018

Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma

por D’Angelo, Sandra P., Hunger, Matthias, Brohl, Andrew S., Nghiem, Paul, Bhatia, Shailender, Hamid, Omid, Mehnert, Janice M., Terheyden, Patrick, Shih, Kent C., Brownell, Isaac, Lebbé, Céleste, Lewis, Karl D., Linette, Gerald P., Milella, Michele, Schlichting, Michael, Hennessy, Meliessa H., Bharmal, Murtuza
Publicado 2019

A Phase I Study of Binimetinib (MEK162) Combined with Pexidartinib (PLX3397) in Patients with Advanced Gastrointestinal Stromal Tumor

por Rosenbaum, Evan, Kelly, Ciara, D'Angelo, Sandra P., Dickson, Mark A., Gounder, Mrinal, Keohan, Mary L., Movva, Sujana, Condy, Mercedes, Adamson, Travis, Mcfadyen, Chloe R., Antonescu, Christina R., Hwang, Sinchun, Singer, Sam, Qin, Li‐Xuan, Tap, William D., Chi, Ping
Publicado 2019

Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma

por Dickson, Mark A., D'Adamo, David R., Keohan, Mary L., D'Angelo, Sandra P., Carvajal, Richard D., Gounder, Mrinal M., Maki, Robert G., Qin, Li-Xuan, Lefkowitz, Robert A., McKennon, Olivia R., Hirst, Catherine M., Schwartz, Gary K., Tap, William D.
Publicado 2015

Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial

por D'Angelo, Sandra P, Bhatia, Shailender, Brohl, Andrew S, Hamid, Omid, Mehnert, Janice M, Terheyden, Patrick, Shih, Kent C, Brownell, Isaac, Lebbé, Celeste, Lewis, Karl D, Linette, Gerald P, Milella, Michele, Georges, Sara, Shah, Parantu, Ellers-Lenz, Barbara, Bajars, Marcis, Güzel, Gülseren, Nghiem, Paul T
Publicado 2020

Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab

por Bharmal, Murtuza, Nolte, Sandra, Lebbé, Céleste, Mortier, Laurent, Brohl, Andrew S, Fazio, Nicola, Grob, Jean-Jacquez, Pusceddu, Sara, Hanna, Glenn J, Hassel, Jessica C, Kiecker, Felix, Ellers-Lenz, Barbara, Bajars, Marcis, Güzel, Gülseren, Nghiem, Paul, Hunger, Matthias, Schlichting, Michael, Henry-Szatkowski, Mickaël, D'Angelo, Sandra P
Publicado 2020

Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced Sarcomas

por Rosenbaum, Evan, Seier, Kenneth, Bradic, Martina, Kelly, Ciara, Movva, Sujana, Nacev, Benjamin A., Gounder, Mrinal M., Keohan, Mary L., Avutu, Viswatej, Chi, Ping, Thornton, Katherine A., Chan, Jason E., Dickson, Mark A., Donoghue, Mark T.A., Tap, William D., Qin, Li-Xuan, D'Angelo, Sandra P.
Publicado 2023

Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma

por Klemen, Nicholas D., Hwang, Sinchun, Bradic, Martina, Rosenbaum, Evan, Dickson, Mark A., Gounder, Mrinal M., Kelly, Ciara M., Keohan, Mary L., Movva, Sujana, Thornton, Katherine A., Chi, Ping, Nacev, Benjamin A., Chan, Jason E., Bartlett, Edmund K., Richards, Allison L., Singer, Samuel, Donoghue, Mark T.A., Tap, William D., D'Angelo, Sandra P.
Publicado 2022

Biomarker correlates with response to NY-ESO-1 TCR T cells in patients with synovial sarcoma

por Gyurdieva, Alexandra, Zajic, Stefan, Chang, Ya-Fang, Houseman, E. Andres, Zhong, Shan, Kim, Jaegil, Nathenson, Michael, Faitg, Thomas, Woessner, Mary, Turner, David C., Hasan, Aisha N., Glod, John, Kaplan, Rosandra N., D’Angelo, Sandra P., Araujo, Dejka M., Chow, Warren A., Druta, Mihaela, Demetri, George D., Van Tine, Brian A., Grupp, Stephan A., Fine, Gregg D., Eleftheriadou, Ioanna
Publicado 2022

Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors: A Phase 1a/1b Nonrandomized Controlled Trial

por Kim, Tae Won, Bedard, Philippe L., LoRusso, Patricia, Gordon, Michael S., Bendell, Johanna, Oh, Do-Youn, Ahn, Myung-Ju, Garralda, Elena, D’Angelo, Sandra P., Desai, Jayesh, Hodi, F. Stephen, Wainberg, Zev, Delord, Jean-Pierre, Cassier, Phillippe A., Cervantes, Andrés, Gil-Martin, Marta, Wu, Benjamin, Patil, Namrata S., Jin, Yanling, Hoang, Tien, Mendus, Diana, Wen, Xiaohui, Meng, Raymond, Cho, Byoung Chul
Publicado 2023

Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumors

por Chi, Ping, Qin, Li-Xuan, Camacho, Niedzica, Kelly, Ciara M., D'Angelo, Sandra P., Dickson, Mark A., Gounder, Mrinal M., Keohan, Mary L., Movva, Sujana, Nacev, Benjamin A., Rosenbaum, Evan, Thornton, Katherine A., Crago, Aimee M., Francis, Jasmine H., Martindale, Moriah, Phelan, Haley T., Biniakewitz, Matthew D., Lee, Cindy J., Singer, Samuel, Hwang, Sinchun, Berger, Michael F., Chen, Yu, Antonescu, Cristina R., Tap, William D.
Publicado 2022